Anika Therapeutics (ANIK) Revenue & Revenue Breakdown
Anika Therapeutics Revenue Highlights
Latest Revenue (Y)
$166.66M
Latest Revenue (Q)
$38.75M
Main Segment (Y)
Joint Preservation and Restoration
Main Geography (Y)
UNITED STATES
Anika Therapeutics Revenue by Period
Anika Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $166.66M | 6.67% |
2022-12-31 | $156.24M | 5.71% |
2021-12-31 | $147.79M | 13.29% |
2020-12-31 | $130.46M | 13.83% |
2019-12-31 | $114.61M | 8.58% |
2018-12-31 | $105.56M | -6.93% |
2017-12-31 | $113.42M | 9.71% |
2016-12-31 | $103.38M | 11.16% |
2015-12-31 | $93.00M | -11.93% |
2014-12-31 | $105.59M | 40.64% |
2013-12-31 | $75.08M | 5.22% |
2012-12-31 | $71.36M | 10.16% |
2011-12-31 | $64.78M | 16.60% |
2010-12-31 | $55.56M | 38.42% |
2009-12-31 | $40.14M | 12.17% |
2008-12-31 | $35.78M | 16.06% |
2007-12-31 | $30.83M | 14.86% |
2006-12-31 | $26.84M | -10.04% |
2005-12-31 | $29.84M | 12.73% |
2004-12-31 | $26.47M | 71.81% |
2003-12-31 | $15.40M | 16.81% |
2002-12-31 | $13.19M | 16.57% |
2001-12-31 | $11.31M | -30.75% |
2000-12-31 | $16.34M | 21.00% |
1999-12-31 | $13.50M | -2.88% |
1998-12-31 | $13.90M | 15.83% |
1997-12-31 | $12.00M | 900.00% |
1996-12-31 | $1.20M | -64.71% |
1995-08-31 | $3.40M | -27.66% |
1994-08-31 | $4.70M | 113.64% |
1993-08-31 | $2.20M | - |
Anika Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $38.75M | -7.56% |
2024-06-30 | $41.92M | 3.45% |
2024-03-31 | $40.52M | -5.70% |
2023-12-31 | $42.97M | 3.63% |
2023-09-30 | $41.47M | -6.40% |
2023-06-30 | $44.30M | 16.82% |
2023-03-31 | $37.92M | -4.29% |
2022-12-31 | $39.62M | -1.59% |
2022-09-30 | $40.26M | 1.53% |
2022-06-30 | $39.66M | 8.08% |
2022-03-31 | $36.69M | 2.43% |
2021-12-31 | $35.82M | -9.40% |
2021-09-30 | $39.54M | 3.65% |
2021-06-30 | $38.15M | 11.24% |
2021-03-31 | $34.29M | 4.91% |
2020-12-31 | $32.69M | 3.14% |
2020-09-30 | $31.69M | 3.31% |
2020-06-30 | $30.68M | -13.33% |
2020-03-31 | $35.40M | 18.89% |
2019-12-31 | $29.77M | 0.25% |
2019-09-30 | $29.70M | -2.37% |
2019-06-30 | $30.42M | 23.04% |
2019-03-31 | $24.72M | -8.28% |
2018-12-31 | $26.96M | 0.63% |
2018-09-30 | $26.79M | -12.31% |
2018-06-30 | $30.55M | 43.66% |
2018-03-31 | $21.26M | -27.64% |
2017-12-31 | $29.39M | 8.11% |
2017-09-30 | $27.18M | -18.76% |
2017-06-30 | $33.46M | 43.09% |
2017-03-31 | $23.39M | -18.59% |
2016-12-31 | $28.73M | 11.39% |
2016-09-30 | $25.79M | -2.98% |
2016-06-30 | $26.58M | 19.29% |
2016-03-31 | $22.28M | -27.87% |
2015-12-31 | $30.89M | 30.46% |
2015-09-30 | $23.68M | 3.40% |
2015-06-30 | $22.90M | 47.57% |
2015-03-31 | $15.52M | -33.26% |
2014-12-31 | $23.25M | 5.44% |
2014-09-30 | $22.06M | -16.06% |
2014-06-30 | $26.27M | -22.74% |
2014-03-31 | $34.01M | 60.04% |
2013-12-31 | $21.25M | 19.70% |
2013-09-30 | $17.75M | -14.76% |
2013-06-30 | $20.83M | 36.61% |
2013-03-31 | $15.25M | -32.55% |
2012-12-31 | $22.61M | 53.09% |
2012-09-30 | $14.77M | -24.76% |
2012-06-30 | $19.62M | 36.66% |
2012-03-31 | $14.36M | -22.14% |
2011-12-31 | $18.44M | -0.06% |
2011-09-30 | $18.46M | 14.34% |
2011-06-30 | $16.14M | 37.51% |
2011-03-31 | $11.74M | -20.27% |
2010-12-31 | $14.72M | 6.15% |
2010-09-30 | $13.87M | -4.35% |
2010-06-30 | $14.50M | 16.31% |
2010-03-31 | $12.47M | 17.39% |
2009-12-31 | $10.62M | -1.61% |
2009-09-30 | $10.79M | 13.33% |
2009-06-30 | $9.52M | 3.51% |
2009-03-31 | $9.20M | 2.62% |
2008-12-31 | $8.97M | -2.60% |
2008-09-30 | $9.21M | 1.60% |
2008-06-30 | $9.06M | 5.98% |
2008-03-31 | $8.55M | -11.20% |
2007-12-31 | $9.63M | - |
Anika Therapeutics Revenue Breakdown
Anika Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Joint Preservation and Restoration | $54.88M | $50.40M | $48.59M | $39.37M | - |
Non-Orthopedic | $9.86M | $7.95M | $9.70M | - | - |
OA Pain Management | - | $97.89M | $89.50M | - | - |
Licensing, Milestone and Contract Revenue | - | - | - | - | - |
Product | - | - | $147.79M | $130.46M | $114.51M |
Joint Pain Management Therapies | - | - | - | $83.03M | - |
Manufactured Product, Other | - | - | - | $8.06M | $6.08M |
Orthobiologics | - | - | - | - | $101.00M |
Surgical | - | - | - | - | $5.18M |
Dermal | - | - | - | - | $2.24M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Orthopedic | $2.38M | $2.36M | $2.60M | $3.11M | $2.31M | $1.84M | $1.53M | $2.78M | $1.82M | $1.82M | - | - | - | - | - | - | - | - | - | - |
Joint Preservation and Restoration | $11.95M | $13.84M | $15.30M | $13.47M | $12.66M | $13.45M | $14.35M | $11.82M | $12.10M | $12.14M | $13.29M | $11.19M | $11.88M | $12.22M | - | - | - | - | - | - |
OA Pain Management | - | - | - | - | $29.33M | $22.63M | $23.75M | $25.66M | $25.74M | $22.73M | - | - | - | - | - | - | - | - | - | - |
Product | - | - | - | - | - | - | - | - | - | $36.69M | $35.82M | $39.54M | $38.15M | $34.29M | $32.69M | $31.69M | $30.68M | $35.40M | $29.77M | $29.61M |
Joint Pain Management Therapies | - | - | - | - | - | - | - | - | - | - | - | $26.15M | $24.32M | $19.32M | $16.86M | $18.44M | $22.25M | $25.48M | - | - |
Manufactured Product, Other | - | - | - | - | - | - | - | - | - | - | - | $2.19M | $1.94M | $2.76M | $2.69M | $1.54M | $1.81M | $2.02M | $1.37M | $1.85M |
Orthopedic Joint Preservation and Restoration Care | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.71M | $6.62M | $7.90M | - | - |
Surgical | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.11M | $578.00K |
Dermal | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.25M | $417.00K |
Orthobiologics | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $26.03M | $26.77M |
Latest
Anika Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Europe | $21.72M | $20.64M | $19.58M | $14.18M | $14.74M |
UNITED STATES | $123.13M | $119.15M | $113.83M | $103.18M | $90.30M |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $27.70M | $29.24M | $32.14M | $30.83M | $32.87M | $27.29M | $31.60M | $31.09M | $29.69M | $26.77M | $27.85M | $30.91M | $30.07M | $25.00M | $25.33M | $26.41M | $25.13M | $26.31M | $23.76M | $23.51M |
Europe | $5.69M | $5.97M | $4.97M | $5.42M | $5.67M | $5.66M | $4.67M | $4.88M | $5.29M | $5.80M | $4.77M | $4.24M | $5.09M | $5.48M | $3.04M | $2.95M | $2.91M | $5.28M | $3.35M | $3.94M |
Latest
Anika Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AVNS | Avanos Medical | $673.30M | $170.40M |
AORT | Artivion | $354.00M | $95.78M |
FNA | Paragon 28 | $216.39M | $61.02M |
ANIK | Anika Therapeutics | $166.66M | $38.75M |
AXGN | AxoGen | $159.01M | $48.64M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SRDX | Surmodics | $126.08M | $30.34M |
SGHT | Sight Sciences | $81.06M | $20.16M |
NPCE | NeuroPace | $65.42M | $21.06M |
CVRX | CVRx | $39.30M | $13.37M |
OSA | ProSomnus | $27.65M | $7.46M |
OFIX | Orthofix Medical | $100.00K | $198.62M |